Literature DB >> 18163537

Synthesis, characterization, antitumor activity of pluronic mimicking copolymer micelles conjugated with doxorubicin via acid-cleavable linkage.

Yuhan Lee1, Sung Young Park, Hyejung Mok, Tae Gwan Park.   

Abstract

Pluronic mimicking poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) triblock copolymer having multiple hydroxyl groups in the PPO middle segment (core-functionalized Pluronic: CF-PLU) was synthesized for conjugation of doxorubicin (DOX). DOX was conjugated on the multiple hydroxyl groups of CF-PLU via an acid-labile hydrazone linkage (CF-PLU-DOX). In aqueous solution, CF-PLU-DOX copolymers self-assembled to form a core/shell-type micelle structure consisting of a hydrophobic DOX-conjugated PPO core and a hydrophilic PEO shell layer. The conjugated DOX from CF-PLU-DOX micelles was released out more rapidly at pH 5 than pH 7.4, indicating that the hydrazone linkage was cleaved under acidic condition. CF-PLU-DOX micelles exhibited greatly enhanced cytotoxicity for MCF-7 human breast cancer cells compared to naked DOX, while CF-PLU copolymer itself showed extremely low cytotoxicity. Flow cytometry analysis revealed that the extent of cellular uptake for CF-PLU-DOX micelles was greater than free DOX. Confocal image analysis also showed that CF-PLU-DOX micelles had a quite different intracellular distribution profile from free DOX. CF-PLU-DOX micelles were mainly distributed in the cytoplasm, endosomal/lysosomal vesicles, and nucleus, while free DOX was localized mainly within the nucleus, suggesting that CF-PLU-DOX micellar formulation might be advantageously used for overcoming the multidrug resistance (MDR) effect, which gradually develops in many tumor cells during repeated drug administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18163537     DOI: 10.1021/bc700382z

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  16 in total

1.  Anthracycline Nano-Delivery Systems to Overcome Multiple Drug Resistance: A Comprehensive Review.

Authors:  Ping Ma; Russell J Mumper
Journal:  Nano Today       Date:  2013-06-01       Impact factor: 20.722

2.  Micellar carrier based on methoxy poly(ethylene glycol)-block-poly(epsilon-caprolactone) block copolymers bearing ketone groups on the polyester block for doxorubicin delivery.

Authors:  He Yueying; Zhang Yan; Gu Chunhua; Dai Weifeng; Lang Meidong
Journal:  J Mater Sci Mater Med       Date:  2009-10-15       Impact factor: 3.896

3.  Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.

Authors:  Renata Jaskula-Sztul; Wenjin Xu; Guojun Chen; April Harrison; Ajitha Dammalapati; Renu Nair; Yiqiang Cheng; Shaoqin Gong; Herbert Chen
Journal:  Biomaterials       Date:  2016-03-08       Impact factor: 12.479

Review 4.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers.

Authors:  Elena V Batrakova; Alexander V Kabanov
Journal:  J Control Release       Date:  2008-04-24       Impact factor: 9.776

Review 5.  Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer.

Authors:  P S Thakur; A M Khan; S Talegaonkar; F J Ahmad; Z Iqbal
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-26       Impact factor: 4.553

6.  Principles of nanoparticle design for overcoming biological barriers to drug delivery.

Authors:  Elvin Blanco; Haifa Shen; Mauro Ferrari
Journal:  Nat Biotechnol       Date:  2015-09       Impact factor: 54.908

7.  Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.

Authors:  Yu-Fen Huang; Dihua Shangguan; Haipeng Liu; Joseph A Phillips; Xiaoling Zhang; Yan Chen; Weihong Tan
Journal:  Chembiochem       Date:  2009-03-23       Impact factor: 3.164

8.  Scope of nanotechnology in ovarian cancer therapeutics.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  J Ovarian Res       Date:  2010-08-06       Impact factor: 4.234

9.  Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro.

Authors:  Yan Hu; Jinhong Duan; Qimin Zhan; Fengdan Wang; Xin Lu; Xian-Da Yang
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

10.  Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer.

Authors:  Ling Meng; Liu Yang; Xiangxuan Zhao; Lucy Zhang; Haizhen Zhu; Chen Liu; Weihong Tan
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.